Articles
-
Schaeffer Center Researchers Make an Impact in Washington
The USC researchers have testified before Congress and informed policymakers tackling drug prices, innovation and medical bills.
Categorized in -
A New Healthcare Valuation Model That Puts Patients First: Generalized Risk Adjusted Cost-Effectiveness (GRACE)
By recognizing that health is worth more to those who have less, GRACE provides a more equitable approach to value assessment and healthcare investments.
Categorized in -
Let the Market Determine Drug Prices – Not 19th Century Economics
In health care, the term “value” gets lobbed about quite loosely. It is easy to forget that centuries of economic thought have gone into rigorously examining how worth is determined in a marketplace.
Categorized in -
In the Wake of the Pandemic: How and Why Housing Plans are Changing in L.A.
Nearly all Angelenos plan to stay put in L.A. Four years ago, they were fleeing in record numbers. What changed in our nation’s most populous county? LABarometer survey data suggest financial constraints kept many low-income residents in place; now, a growing number of these residents appear at risk of displacement.
Categorized in -
Medicare Can Follow Blazed Trails to Revitalize Alzheimer’s Care
If Medicare is allowed to step up to the challenge of Alzheimer’s, patients could receive affordable and good quality care as soon as their disease develops.
Categorized in -
USC-Led Study Leverages Artificial Intelligence to Predict Risk of Bedsores in Hospitalized Patients
A new study in BMJ Open presents a new model for predicting patients most at risk of bedsores in hospitals
Categorized in -
Medicare Coverage of Weight Loss Drugs Could Save the U.S. Billions of Dollars
The new weight loss drugs work, and represent huge value in treating obesity. Even though they are expensive, broader access to them via Medicare would end up saving the U.S. money.
Categorized in -
USC Schaeffer Center Study Finds Few Hospitals Promoting Potentially Predatory Medical Payment Products
As Americans struggle to pay off billions of dollars of medical debt, consumer advocates are looking to rein in predatory lending practices. But a recent USC study finds concerns about hospitals offering medical payment products may be overblown.
Categorized in -
Buyouts Can Bring Relief From Medical Debt, but They’re Far From a Cure
Local governments are increasingly buying – and forgiving – their residents’ medical debt.
Categorized in -
Medicare Part D Plans Increased Restrictions on Drug Coverage
Medicare Part D plans excluded more compounds from coverage or subjected more of them to review before patients can access treatments, USC researchers found.
Categorized in